Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Subsets of mammalian adult stem cells reside in a reversible quiescent state. Recent studies of epigenetic, transcriptional and post-transcriptional events underlying quiescence suggest that this state is actively maintained by signalling pathways that keep cells poised for rapid activation, rather than this being a dormant state with minimal basal activity.
The methylation of cytosine bases in DNA has a key role in regulating transcription. It has recently been discovered that ten-eleven translocation (TET) proteins can reverse DNA methylation, refining our view of how changes in DNA methylation are coupled to different cellular processes.
Pluripotent stem cell lines differ in their capacity to differentiate into desired cell typesin vitro. Genetic and epigenetic variations contribute to functional variability between cell lines and heterogeneity within single clones. Characterizing such variations is important for the use of pluripotent stem cells in disease modelling and developmental processes and for their applications in regenerative medicine.
Through their role as substrate adaptors for S phase kinase-associated protein 1 (SKP1)–cullin 1 (CUL1)–F-box protein (SCF) ubiquitin ligase complexes, F-box proteins control the degradation of a large number of proteins with wide-ranging functions. Studying the mechanisms of substrate recruitment by F-box proteins has increased our understanding of their dysregulation in disease and might lead to targeted therapies.
The distinct organization of the endoplasmic reticulum (ER)–Golgi interface across species reflects variation in the mechanisms that control transport between these organelles. Continued comparative analyses of this interface should help to elucidate the ways that ER–Golgi trafficking control can be adapted to meet cell type-specific needs.
The past few years have marked significant anniversaries in the field of signal transduction. Here, six researchers reflect on the context in which these discoveries were made, and how our concept of cell signalling has evolved during the past three decades.